Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2012
07/31/2012US8232310 Targeting of EWS-FLI1 as anti-tumor therapy
07/31/2012US8232308 Methods for treating a disease in which Rho kinase is involved
07/31/2012US8232297 Sulphonylpyrroles as inhibitors of HDACs novel sulphonylpyrroles
07/31/2012US8232296 Salt 628
07/31/2012US8232292 Sulfonamide compound and crystal thereof
07/31/2012US8232291 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/31/2012US8232285 Quinazolinone compounds and methods of use thereof
07/31/2012US8232274 Pyridazinone derivatives useful as glucan synthase inhibitors
07/31/2012US8232271 Heterocyclic antiviral compounds
07/31/2012US8232269 Amide compounds useful in therapy
07/31/2012US8232263 17,20(Z)-dehydro vitamin D analogs and their uses
07/31/2012US8231984 Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same
07/31/2012CA2666310C Substituted imidazoles as bombesin receptor subtype-3 modulators
07/31/2012CA2565599C Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
07/31/2012CA2553877C Compounds useful for the synthesis of s- and r-omeprazole and a process for their preparation
07/31/2012CA2539909C 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo(2,3-c) pyridin-2-ylmethyl) pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes
07/31/2012CA2516186C Pyridine derivatives as fungicidal compounds
07/31/2012CA2503445C Methylene urea derivatives as raf-kinase inhibitors
07/26/2012WO2012100229A2 Compositions and methods for cardiovascular disease
07/26/2012WO2012100135A1 Picolinamide inhibitors of kinases
07/26/2012WO2012099219A1 Organic electroluminescent element
07/26/2012WO2012098416A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
07/26/2012WO2012098132A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
07/26/2012WO2012098070A1 Quinoline dyrk1 inhibitors
07/26/2012WO2012075492A3 Carbocycle-substituted purine and 7-deazapurine compounds
07/26/2012WO2012066488A3 Bridged spiro[2.4]heptane ester derivatives
07/26/2012US20120190853 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
07/26/2012US20120190852 Medical composition for treatment or prophylaxis of glaucoma
07/26/2012US20120190845 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
07/26/2012US20120190711 Lenalidomide salts
07/26/2012US20120190707 Selective inhibitors of akt and methods of using same
07/26/2012US20120190700 Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer
07/26/2012US20120190699 Pyridones useful as inhibitors of kinases
07/26/2012US20120190695 Phenyloxadiazole derivatives as pgds inhibitors
07/26/2012US20120190694 Selective sphingosine-1-phosphate receptor antagonists
07/26/2012US20120190687 Pyrazinylpyrazoles
07/26/2012US20120190686 Bicyclo[3.2.1]octyl amide derivatives and uses of same
07/26/2012US20120190684 Insecticidal substituted azinyl derivatives
07/26/2012US20120190682 Modulators for amyloid beta
07/26/2012US20120190681 Picolinamide inhibitors of kinases
07/26/2012US20120190680 Heteroaryl Amide Analogues
07/26/2012US20120190677 Novel tetrahydroquinoline derivatives
07/26/2012US20120190666 Heteroaryl Compounds as PIKK Inhibitors
07/26/2012US20120190579 Functionalisation of Solid Substrates
07/26/2012US20120190543 Pesticidal compositions
07/26/2012US20120189539 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
07/26/2012US20120186396 Compounds useful as ligands of actinides, their synthesis and their uses
07/26/2012CA2825367A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
07/26/2012CA2824544A1 Picolinamide inhibitors of kinases
07/26/2012CA2823780A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
07/25/2012EP2479175A1 Compounds and methods for treating dyslipidemia
07/25/2012EP2479174A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
07/25/2012EP2479173A1 Therapeutic agents useful for treating pain
07/25/2012EP2479172A1 Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines
07/25/2012EP2479168A1 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists
07/25/2012EP2477980A1 Hcv protease inhibitors
07/25/2012EP2477977A2 Treatment for oxidative stress and/or hypertension
07/25/2012EP2477976A1 Quinazolinone derivatives as viral polymerase inhibitors
07/25/2012EP2477975A1 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same
07/25/2012EP2477974A2 Nicotine haptens, immunoconjugates and their uses
07/25/2012EP2477973A1 Process for the preparation of a crystalline form of lenalidomide
07/25/2012EP2477967A1 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
07/25/2012EP2477631A1 Substituted phenylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/25/2012EP2477630A1 Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/25/2012EP2477629A1 Substituted heteroarylamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/25/2012EP2477492A1 Substituted heteroarylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/25/2012EP2205558B1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
07/25/2012EP1891063B1 Bicyclic derivatives as modulators of ion channels
07/25/2012EP1723121B1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
07/25/2012EP1699783B1 Opioid receptor antagonists
07/25/2012EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
07/25/2012EP1270557B1 Ethylenediamine derivatives
07/25/2012EP1257544B1 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
07/25/2012EP1252162B1 Alpha v integrin receptor antagonists
07/25/2012CN102612517A Method for producing dabigatran etexilate
07/25/2012CN102612516A Substituted pyrrolidine-2-carboxamides
07/25/2012CN102612515A 2-amino-9-[4-(4-methoxy-phenoxy) - piperid in -1-yl] -4-phenyl-indeno [1,2-d] pyrimidin -5 -one and its use as a highly selective adenosine a2a receptor antagonist
07/25/2012CN102603780A Coordination polymer with three-dimensional open-framework structure as well as preparation and application thereof
07/25/2012CN102603717A Pyrrylketone compound and application thereof as drug
07/25/2012CN102603716A Method for preparing (S)-pantoprazole in high-enantioselectivity way
07/25/2012CN102603715A Synthesis and preparation method of fasudil hydrochloride
07/25/2012CN102603714A Method for synthesizing sulfinyl compound with single optical-configuration
07/25/2012CN102603713A Chiral CB1 (cannabinoid) receptor inhibitor, and preparation method and medical application thereof
07/25/2012CN102603712A S-type and R-type tetrahydro-naphthalene amides antitumor compound and pharmaceutically acceptable salt or pro-drug thereof, preparation method and application
07/25/2012CN102603711A Pyridine carboxamides as 11-beta-hsd1 inhibitors
07/25/2012CN102603710A Preparation method of imatinib intermediate
07/25/2012CN102603695A Amino acid-fluorophore compound and application thereof
07/25/2012CN102603660A Preparation method of 1H-1,2,3-triazole compound
07/25/2012CN102603621A Novel chiral sulfoxide compound and method for preparing esomeprazole by using novel chiral sulfoxide compound
07/25/2012CN102603619A Compound with anticancer activity and preparation method thereof
07/25/2012CN102603610A 1,3-dihydro-1-oxo-2H-isobenzazole compounds as well as preparation method and use thereof
07/25/2012CN102600217A Process for extracting orixine
07/25/2012CN101899013B 2-(2-substituted aryl-2H-1,2,4-triazole-3-sulfydryl) acetamide derivative and preparation method and application thereof
07/25/2012CN101628912B Anti-tumor compound containing triazole heterocyclic structure and application thereof
07/24/2012US8227614 Methods of nanoassembly of a fractal polymer and materials formed thereby
07/24/2012US8227504 Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof
07/24/2012US8227489 N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
07/24/2012US8227485 Benzimidazole and imidazopyridine derivatives and use thereof as a medicament
07/24/2012US8227481 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
07/24/2012US8227469 Vanilloid receptor ligands and their use in treatments
1 ... 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 ... 1080